Evgen Pharma talks through clinical milestones and financial results from its 2022 full year report - Huw Jones, CEO, Evgen Pharma 00:00:00
Evgen Pharma CEO Huw Jones tells Proactive the clinical stage drug development company developing sulforaphane-based medicines for the treatment of multiple diseases is in 'deep planning mode' for its two upcoming clinical trials.